Back Pain
Sensorimotor retraining alleviates chronic back pain
A novel treatment designed to help patients with chronic lower back pain change their perceptions of pain and function through neural processing significantly lowered pain intensity and improved disability, data show.
About 35% of patients with non-radiographic axial SpA told disease is ‘in their head’
ORLANDO, Fla. — Many patients with non-radiographic axial spondyloarthritis experience symptoms for nearly a decade before receiving a diagnosis, according to a presenter at the 2022 Rheumatology Nurses Society Conference.
Nucleus replacement devices may yield excellent long-term results in select patients
Use of a nucleus replacement device may provide “excellent” long-term clinical and radiological outcomes in select patients, according to researchers of published results.
Top in rheumatology: Aquatic exercise for back pain, RCTs on connective tissue disease
A recent study found that patients with chronic lower back pain who underwent therapeutic aquatic exercise saw greater improvements than those who underwent physical therapy. It was the top story in rheumatology last week.
Nevro receives FDA expanded labeling approval for spinal cord stimulation system
Aquatic exercise superior to physical therapy in relieving chronic lower back pain
Therapeutic aquatic exercise results in greater lower back pain relief than physical therapy, and demonstrates long-term effects for up to 12 months, according to data published in JAMA Network Open.
Virtual reality program for back pain superior to sham device 3 months after treatment
Three months after a cohort of patients used a home-based therapeutic virtual reality program called EaseVRx, data indicated it was superior to a sham device in several clinical measures related to the user’s chronic lower back pain.
Artificial neural network accurately detects sacroiliitis in suspected axial SpA
A newly developed artificial neural network can accurately detect radiographic sacroiliitis in patients with suspected axial spondyloarthritis, according to data presented at ACR Convergence 2021.
Upadacitinib improves signs, symptoms of ankylosing spondylitis, nonradiographic axSpA
Upadacitinib significantly reduced signs and symptoms of both ankylosing spondylitis and nonradiographic axial spondyloarthritis, as well as improved physical function and disease activity, according to a pair of phase 3 studies from AbbVie.
One pain class noninferior to cognitive behavioral therapy for lower back pain
A single 2-hour pain management class provided as much pain catastrophizing benefit as eight 2-hour sessions of cognitive behavioral therapy in adults with chronic low back pain, according to results of a randomized clinical trial.